Roivant Sciences Ownership | Who Owns Roivant Sciences?
Roivant Sciences Ownership Summary
Roivant Sciences is owned by 76.69% institutional investors, 29.56% insiders. Sb investment advisers (uk) is the largest institutional shareholder, holding 8.89% of ROIV shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 2.92% of its assets in Roivant Sciences shares.
ROIV Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Roivant Sciences | 76.69% | 29.56% | -6.24% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Sb investment advisers (uk) | 71.36M | 8.89% | $754.29M |
Viking global investors lp | 69.16M | 8.61% | $730.98M |
Qvt financial lp | 66.72M | 8.31% | $705.23M |
Fmr | 46.55M | 5.80% | $492.05M |
Blackrock | 35.37M | 4.41% | $373.86M |
Morgan stanley | 29.33M | 3.65% | $310.02M |
Rubric capital management lp | 23.00M | 2.86% | $243.11M |
State street | 18.44M | 2.30% | $194.94M |
Patient square capital lp | 12.23M | 1.52% | $129.25M |
Two seas capital lp | 10.32M | 1.29% | $109.07M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Qvt financial lp | 66.72M | 66.32% | $705.23M |
Patient square capital lp | 12.23M | 59.99% | $129.25M |
Atalaya capital management lp | 1.71M | 40.31% | $18.13M |
Two seas capital lp | 10.32M | 17.73% | $109.07M |
Anchorage capital group | 4.83M | 15.77% | $51.08M |
Whitefort capital management, lp | 2.39M | 15.58% | $25.27M |
Tejara capital | 2.18M | 8.39% | $23.08M |
Tyro capital management | 1.74M | 8.36% | $18.44M |
Adar1 capital management | 4.15M | 8.28% | $43.87M |
Sb investment advisers (uk) | 71.36M | 6.97% | $754.29M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Fmr | 46.55M | 0.03% | 11.21M |
Invesco | 5.91M | 0.01% | 5.40M |
Norges bank | 4.24M | 0.01% | 4.24M |
Rubric capital management lp | 23.00M | 6.37% | 3.00M |
Troluce capital advisors | 2.95M | 3.06% | 2.95M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Morgan stanley | 29.33M | 0.02% | -6.31M |
Avoro capital advisors | - | - | -4.65M |
Baker bros. advisors lp | 2.80M | 0.38% | -4.62M |
Woodline partners lp | 8.00M | 0.81% | -3.17M |
Bvf inc/il | - | - | -2.74M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 4.24M | 0.01% | 4.24M | $44.83M |
Troluce capital advisors | 2.95M | 3.06% | 2.95M | $31.18M |
Melqart asset management (uk) | 1.27M | 1.11% | 1.27M | $13.38M |
Alyeska investment group | 1.00M | 0.06% | 1.00M | $10.57M |
Pearl river capital | 490.44K | 0.82% | 490.44K | $5.18M |
Sold Out
Holder | Change |
---|---|
Venturi wealth management | -99.00 |
Walleye capital | -121.00 |
Thurston, springer, miller, herd & titak | -200.00 |
Tyler-stone wealth management | -250.00 |
Versant capital management | -257.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 306 | 0.66% | 564,022,060 | 3.35% | 76 | 1.39% | 177 | 4.12% | 69 | -14.81% |
Jun 30, 2024 | 303 | 14.34% | 545,755,248 | 3.61% | 67 | 1.57% | 169 | 6.29% | 81 | 24.62% |
Mar 31, 2024 | 265 | 10.88% | 526,729,372 | -2.70% | 65 | 1.60% | 159 | 8.90% | 65 | 22.64% |
Dec 31, 2023 | 239 | 10.65% | 541,335,285 | -0.37% | 64 | 1.25% | 146 | 3.55% | 53 | 10.42% |
Sep 30, 2023 | 216 | 15.51% | 543,371,178 | 9.12% | 71 | 1.47% | 141 | 20.51% | 48 | 4.35% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 21.59M | 2.92% | 443.75K |
Fidelity Growth Compy Commingled Pl O | 21.15M | 2.86% | 439.20K |
Fidelity Growth Company Fund | 15.78M | 2.13% | 219.66K |
Vanguard Total Stock Mkt Idx Inv | 14.00M | 1.91% | -40.70K |
iShares Core S&P Mid-Cap ETF | 13.74M | 1.86% | 7.44K |
Vanguard Small Cap Index | 11.13M | 1.52% | 21.78K |
SPDR® S&P Biotech ETF | 7.24M | 0.98% | 80.09K |
Vanguard Institutional Extnd Mkt Idx Tr | 6.42M | 0.88% | -22.72K |
Vanguard Small Cap Growth Index Inv | 6.12M | 0.83% | -14.21K |
Fidelity Growth Company K6 | 5.22M | 0.71% | -13.82K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 20, 2024 | Venker Eric | President & COO | Sell | $1.13M |
Oct 21, 2024 | Venker Eric | President & COO | Sell | $1.17M |
Sep 25, 2024 | QVT Financial LP | Director by Deputization | Sell | $588.50K |
Sep 26, 2024 | QVT Financial LP | Director by Deputization | Sell | $10.35M |
Sep 25, 2024 | MANCHESTER KEITH S | - | Sell | $1.59M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 2 |
2024 Q3 | - | 12 |
2024 Q2 | - | - |
2024 Q1 | - | 2 |
2023 Q4 | - | 3 |
ROIV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools